M. Emanuel

Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial.

S. Steinberg, B. Turkbey, R. Braylan, 2021, JAMA oncology.

Thalidomide and its sequelae

A. Breckenridge, M. Rawlins, GordonW. Duff, 2012, The Lancet.

Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma

S. Steinberg, K. Camphausen, P. Choyke, 2021, The oncologist.

Severe oral mucositis (SOM) mitigation by genetically modified lactococcus lactis bacteria (LLB) producing human trefoil factor 1 (hTFF1; AG013) in patients being treated with concomitant chemoradiation (CRT) for oral and oropharyngeal cancers (OCOPC)

Yuhchyau Chen, S. Sonis, S. Thatcher, 2019, Annals of Oncology.